PDS BIOTECHNOLOGY CORPORATION
PDSB US70465T1079
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Glover Stephen C. |
1.66 USD |
15,061 Bought |
25,001 USD |
28/02/2025 | 28/02/2025 |
Freitag Gregory Gene |
1.66 USD |
15,060 Bought |
25,000 USD |
28/02/2025 | 28/02/2025 |